Disclosures
The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.
Working with HCPs/ORDMs and HCOs
Merz Therapeutics is committed to compliance and working within the ABPI Code of Practice and applicable laws. For payments made to HCPs/ORDMs and HCOs, including R&D projects in the last 3 years, please refer to the ABPI Disclosure Database:
Working with patient groups
Merz Therapeutics have also made the following contributions to working with patient groups:
| Organisation | Amount | Description |
| The Dystonia Society | £500.00 | Contribution towards the cost of a meeting |
| The Stroke Association | £4180.00 | Contribution towards the cost of the UK Stroke Forum Conference 2018. In return Merz UK received stand space at the event |
| The Stroke Association | £1250.00 | Contribution towards the cost of the Northern Ireland Stroke Conference 2018. In return Merz UK received stand space at the event |
| Organisation | Amount | Description |
| Motor Neurone Disease Association | £200.00 | Thetford study day |
| UK Ntl Intrathecal Baclofen Trust | £500.00 | Sponsorship of NIB Meeting 14.6.19 |
| The British Voice Association | £500.00 | Exhibiting at the BVA event 7.7.19 |
| The Dystonia Society | £418.00 | – |
| Organisation | Amount | Description |
| European Parkinson’s Disease Association (through Merz Pharma GmbH & Co KGaA | £30,314.00 | EPDA’s 2020 Gold Partnership tier |
| The Dystonia Society | £800.00 | Dystonia UK webinar grant |
| Organisation | Amount | Description |
| Parkinson’s UK | £20,600.00 | Education and training modules for healthcare professionals |
| Dystonia UK (through Merz Pharma GmbH & Co KGaA) | £10,000.00 | Grant for animated educational video |
| European Parkinson’s Disease Association (through Merz Pharma GmbH & Co KGaA) | £42,500.00 | EPDA’s 2021 Diamond Sponsorship |
| Organisation | Amount | Description |
Parkinson’s Europe, formerly EPDA (through Merz Pharma GmbH & Co KGaA) | €55,000 | 2022 Diamond Sponsorship |
Parkinson’s UK | £11,000 | Gold Plus sponsorship of Excellence Network conference |
M-MT-UKI-0191 Date of Preparation June 2023